Each of the 45 recommendations has been graded from A to D according to the process described in Appendix A. The grade reflects the degree of ‘trust’ that the clinician can place on the clinical application of the recommendation. The National Osteoporosis Guideline Review Committee supports all recommendations and intends they are used in conjunction with clinical judgement and patient preferences. The recommendations do not cover complex medical conditions and comorbidities, nor are they a substitute for individualised specialist advice and/or consultation. The Review Committee supports and encourages dialogue between GPs and specialists, if required for optimisation of patient care.
Recommendations marked with an asterisk (*) underwent a focused detailed published literature search by RACGP library staff, during which the following databases were interrogated to identify publications subsequent to the previous Edition, ie since 2016:
- PubMed/Medline
- NICE
- United States Preventive Services Task Force
- Cochrane database of systematic reviews
- Canadian Task Force on Preventive Health Care
- SIGN
- Trip database
- Google
These were then reviewed by a bone expert with subspeciality expertise in the topic and the relevant chapter(s) updated. The final draft of the chapter(s) underpinning that relevant recommendation(s) was then reviewed by the National Osteoporosis Guideline Review Committee and discussed at two face-to-face meetings.
All other recommendations have been updated by a bone expert with subspeciality expertise in the area and then reviewed by the National Osteoporosis Guideline Review Committee at two face-to-face meetings.